Search
- Cost Estimate
As ordered reported by the House Committee on Veterans’ Affairs on December 5, 2023
- Blog Post
To enhance its work for the Congress, CBO is looking for new research that examines how changes in pharmaceutical companies’ expected future profits affect the development of new drugs and health outcomes.
- Cost Estimate
As ordered reported by the House Committee on Foreign Affairs on November 29, 2023
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 26, 2023
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on September 28, 2023
- Presentation
Presentation to the Congressional Data Task Force by Kevin Perese, a senior adviser for data science and transparency.
- Cost Estimate
As introduced on July 25, 2023
- Cost Estimate
As ordered reported by the House Committee on Foreign Affairs on November 14, 2023
- Cost Estimate
As ordered reported by the House Committee on Financial Services on November 14, 2023
- Cost Estimate
As ordered reported by the House Committee on Natural Resources on October 26, 2023